What is ICD-10 code C4A.62?

C4A.62 is the ICD-10-CM diagnosis code for Merkel cell carcinoma of left upper limb, including shoulder. A rare aggressive skin cancer (Merkel cell carcinoma) that develops on the left arm or shoulder area, including the upper limb. It belongs to the ICD-10-CM chapter for neoplasms (c00-d49). C4A.62 is a billable code, meaning it can be reported on a claim as a primary or secondary diagnosis when supported by documentation. C4A.62 is part of the FY2026 ICD-10-CM code set published by the CMS National Center for Health Statistics and used on Medicare, Medicaid, and commercial claims in the United States.

Yes. C4A.62 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. C4A.62 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

Which HCC does C4A.62 map to under V28?

C4A.62 maps to CMS-HCC V28 21 (Lymphoma and Other Cancers). The category number and label come from the CMS-HCC V28 model file for payment year 2026.

What does C4A.62 pay in RAF?

C4A.62 carries a community, non-dual, aged (CNA) RAF weight of 0.671 under CMS-HCC V28 for payment year 2026. The weight comes from the CMS V28 relative-factor file, not a hand-typed table.

What is the V28 vs V24 difference for C4A.62?

CMS phased in the V28 risk adjustment model over payment years 2024 (33%), 2025 (67%), and 2026 (100%), replacing V24. V28 consolidates HCC categories, removes some lower-acuity conditions, and recalibrates RAF weights across the entire model. For C4A.62, V28 maps to Lymphoma and Other Cancers at RAF 0.671 while V24 mapped to Breast, Prostate, and Other Cancers and Tumors at RAF 0.150. Both models can still appear in legacy data and in payer-specific lookback periods.

2026 ICD-10-CM C4A.62: Merkel cell carcinoma

C4A.62 maps to CMS-HCC V28 21 (RAF 0.671). Documentation must support MEAT. MEAT criteria · RAF calculator · HCC coding software

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC4A.62Effective periodFY2026 Apr Update (Apr 1-Sep 30)

FY 2026 Apr update / Neoplasms (C00-D49) / Melanoma and other malignant neoplasms of skin (C43-C44)

C4A.62

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Merkel cell carcinoma of left upper limb, including shoulder

A rare aggressive skin cancer (Merkel cell carcinoma) that develops on the left arm or shoulder area, including the upper limb.

Buddy Insight

Merkel cell carcinoma of the left upper limb, including shoulder is a rare aggressive neuroendocrine skin cancer.

CMS-HCC V28

Mapped

HCC 21

Lymphoma and Other Cancers

RAF 0.671

CMS-HCC V24

Mapped

HCC 12

Breast, Prostate, and Other C...

RAF 0.150

ACA/HHS

Mapped

HCC 12

HHS-HCC 12

Varies by metal level

ESRD/PACE

Mapped

HCC 12

Breast, Prostate, and Other C...

RAF 0.045

RXHCC

Mapped

HCC 22

Cancer, Other Specified Sites

RAF 0.124

Code Book Path

Official

C4AMerkel cell carcinoma

C4A.6Merkel cell carcinoma of upper limb, including shoulder

C4A.62Merkel cell carcinoma of left upper limb, including shoulder

Inclusion Terms

Official

ICD-10-CM does not list inclusion terms for C4A.62 in this effective period.

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for C4A.62 in this effective period.

Related Child Codes

Official

C4A.60Merkel cell carcinoma of unspecified upper limb, including shoulder

C4A.61Merkel cell carcinoma of right upper limb, including shoulder

Includes

Official

ICD-10-CM does not list Includes notes for C4A.62 in this effective period.

Excludes 1

Official

ICD-10-CM does not list Excludes 1 notes for C4A.62 in this effective period.

Code First

Official

ICD-10-CM does not list Code First sequencing instructions for C4A.62 in this effective period.

Use Additional

Official

ICD-10-CM does not list Use Additional Code instructions for C4A.62 in this effective period.

Code Also

Official

ICD-10-CM does not list Code Also instructions for C4A.62 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance

Histopathologic confirmation of Merkel cell carcinoma with immunohistochemistry

Laterality documented as left

Specific upper limb subsite (shoulder, upper arm, forearm, wrist, hand, fingers)

Tumor dimensions and depth

MEAT Support

HCC Buddy guidance

Histopathologic confirmation of Merkel cell carcinoma with immunohistochemistry

Laterality documented as left

Specific upper limb subsite (shoulder, upper arm, forearm, wrist, hand, fingers)

Tumor dimensions and depth

Audit Caution

HCC Buddy guidance

Confusing right vs. left laterality — verify against pathology and operative reports

Using C44 upper limb skin cancer codes instead of C4A for Merkel cell carcinoma

Assigning shoulder lesions to trunk codes (C4A.59) when the shoulder is included in upper limb codes

Not distinguishing Merkel cell carcinoma from squamous cell carcinoma or melanoma clinically — histopathology required

Common Mistakes

HCC Buddy guidance

C4A.61 — Merkel cell carcinoma of right upper limb; laterality reversed

C4A.60 — Merkel cell carcinoma of unspecified upper limb; use only when laterality is not documented

C44.621 — Other malignant neoplasm of left upper limb skin; for non-Merkel cell skin cancers

C43.62 — Melanoma of left upper limb including shoulder; different histology

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C4A.62 an HCC code?

Yes. C4A.62 (Merkel cell carcinoma of left upper limb, including shoulder) maps to Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24), with a community non-dual aged RAF of 0.671. It is billable for payment year 2026.

Coder answer: C4A.62 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code: C4A.62
Description: Merkel cell carcinoma of left upper limb, including shoulder
HCC (V28): HCC 21 — Lymphoma and Other Cancers
RAF: 0.671
Billable: Yes
Payment year: 2026

HCC Category Mapping

V28HCC 21, Lymphoma and Other Cancers

0.671

V24HCC 12, Breast, Prostate, and Other Cancers and Tumors

0.150

ESRDHCC 12, Breast, Prostate, and Other Cancers and Tumors

0.045

RxHCCHCC 22, Cancer, Other Specified Sites

0.124

Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

Work C4A.62 in the Code Book — tabular path, V28 RAF, and MEAT checklist →

MEAT Criteria for C4A.62

For C4A.62 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.

MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
EEvaluate: test results, medication response, or physical findings reviewed by the provider
AAssess: explicit mention in the assessment or plan with acknowledgment of status
TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C4A.62 during that encounter, not just copy-forwarded from a problem list.

Coder workflow notes

Get the V28 RAF + MEAT cheat sheet

One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C4A.62 is the ICD-10-CM diagnosis code for merkel cell carcinoma of left upper limb, including shoulder. A rare aggressive skin cancer (Merkel cell carcinoma) that develops on the left arm or shoulder area, including the upper limb. C4A.62 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering melanoma and other malignant neoplasms of skin (c43-c44).

Under the CMS-HCC V28 risk adjustment model, C4A.62 maps to Lymphoma and Other Cancers (HCC 21) with a community, non-dual, aged base RAF weight of 0.671. Under the older CMS-HCC V24 model, C4A.62 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

The '6' in the code indicates upper limb location; the '2' specifies left side. Because C4A.62 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C4A.62 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

•The '6' in the code indicates upper limb location; the '2' specifies left side
•Ensure laterality is clearly documented in the medical record to support correct code selection

Clinical Significance

Merkel cell carcinoma of the left upper limb, including shoulder is a rare aggressive neuroendocrine skin cancer. Upper extremity Merkel cell carcinoma has access to axillary lymphatic drainage, making sentinel lymph node biopsy of axillary nodes critical for staging. Sun exposure on the forearms and dorsal hands increases risk in this anatomical region.

Documentation Requirements

✓Histopathologic confirmation of Merkel cell carcinoma with immunohistochemistry
✓Laterality documented as left
✓Specific upper limb subsite (shoulder, upper arm, forearm, wrist, hand, fingers)
✓Tumor dimensions and depth
✓Axillary sentinel lymph node biopsy status and results
✓Staging and treatment plan documentation

Commonly Confused Codes

•C4A.61: Merkel cell carcinoma of right upper limb; laterality reversed
•C4A.60: Merkel cell carcinoma of unspecified upper limb; use only when laterality is not documented
•C44.621: Other malignant neoplasm of left upper limb skin; for non-Merkel cell skin cancers
•C43.62: Melanoma of left upper limb including shoulder; different histology
•C4A.59: Merkel cell carcinoma of other trunk; shoulder area overlaps with trunk